熔点	129-130 ºC**
密度	1.224±0.06 g/cm3 (20 º

没有数据	没有数据

来源	SDS样本
没有数据	没有数据

产品合成路线

更多

名称	CAS号

更多

文章

同行评议文献

The use of a membrane filtration device to form dried plasma spots for the quantitative determination of guanfacine in whole blood.Yuanyuan Li et al.Rapid communications in mass spectrometry : RCM, 26(10), 1208-1212 (2012-04-14) Guanfacine ER for the treatment of adolescent attention-deficit/hyperactivity disorder.Oscar Gary Bukstein et al.Expert opinion on pharmacotherapy, 13(15), 2207-2213 (2012-09-11) Guanfacine effects on stress, drug craving and prefrontal activation in cocaine dependent individuals: preliminary findings.Helen C Fox et al.Journal of psychopharmacology (Oxford, England), 26(7), 958-972 (2012-01-12) Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy.Tamara Pringsheim et al.Canadian journal of psychiatry. Revue canadienne de psychiatrie, 57(3), 133-143 (2012-03-09) Cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparison.M Haim Erder et al.Applied health economics and health policy, 10(6), 381-395 (2012-11-02) Treatment of guanfacine toxicity with naloxone.Daniel S Tsze et al.Pediatric emergency care, 28(10), 1060-1061 (2012-10-05) Efficacy of guanfacine extended release in the treatment of combined and inattentive only subtypes of attention-deficit/hyperactivity disorder.Floyd R Sallee et al.Journal of child and adolescent psychopharmacology, 22(3), 206-214 (2012-05-23) Guanfacine modulates the influence of emotional cues on prefrontal cortex activation for cognitive control.Kurt P Schulz et al.Psychopharmacology, 226(2), 261-271 (2012-10-23) The behavioural response of mice lacking NK₁ receptors to guanfacine resembles its clinical profile in treatment of ADHD.Katharine Pillidge et al.British journal of pharmacology, 171(20), 4785-4796 (2014-07-31) Clinical trials: new opportunities.Sandra Bond Chapman et al.The journals of gerontology. Series A, Biological sciences and medical sciences, 67(7), 773-780 (2012-05-10) Cost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit hyperactivity disorder in children and adolescents.Vanja Sikirica et al.PharmacoEconomics, 30(8), e1-15 (2012-07-14) Treatment of cocaine withdrawal anxiety with guanfacine: relationships to cocaine intake and reinstatement of cocaine seeking in rats.Deanne M Buffalari et al.Psychopharmacology, 223(2), 179-190 (2012-04-25) Guanfacine ameliorates hypobaric hypoxia induced spatial working memory deficitsKauser H, et al. Physiology & Behavior, 123, 187-192 (2014) Treatment of cocaine withdrawal anxiety with guanfacine: relationships to cocaine intake and reinstatement of cocaine seeking in rats.Deanne M Buffalari et al.Psychopharmacology, 223(2), 179-190 (2012-04-25) Functional effects of alcohol withdrawal syndrome on peripheral sympathetic neurotransmission in vas deferens of adult rats.Guilherme Henrique Souza Bomfim et al.Life sciences, 108(1), 34-43 (2014-05-17) A HPLC-MS method to detect and quantify guanfacine in urine.Carl E Wolf et al.Clinical chemistry and laboratory medicine, 50(3), 535-537 (2011-11-25) Guanfacine hydrochloride: a centrally acting antihypertensive agent.L A Cornish Clinical pharmacy, 7(3), 187-197 (1988-03-01) A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorder.Timothy E Wilens et al.Journal of the American Academy of Child and Adolescent Psychiatry, 51(1), 74-85 (2011-12-20) Guanfacine produces differential effects in frontal cortex compared with striatum: assessed by phMRI BOLD contrastEaston N, et al. Psychopharmacology, 189(3), 369-385 (2006) Metabolic, toxicological, and safety considerations for drugs used to treat ADHD.Sophie Duong et al.Expert opinion on drug metabolism & toxicology, 8(5), 543-552 (2012-03-15) Researchers seek new ways to counter the harmful toll of stress on the brain.M J Friedrich JAMA, 309(4), 330-332 (2013-01-24) Onset of abnormal movements and cardiovascular symptoms after acute change in complex polypharmacy in a child with attention-deficit/hyperactivity disorder and mood symptoms.Presenters Ornella Potter et al.Journal of child and adolescent psychopharmacology, 22(5), 388-392 (2012-10-23) Guanfacine promotes neuronal survival in medial prefrontal cortex under hypobaric hypoxiaKauser H, et al. Brain Research, 1636, 152-160 (2016) Semi-automated direct elution of dried blood spots for the quantitative determination of guanfacine in human blood.Yuanyuan Li et al.Bioanalysis, 4(12), 1445-1456 (2012-07-17) Guanfacine for the treatment of cognitive disorders: a century of discoveries at Yale.Amy F T Arnsten et al.The Yale journal of biology and medicine, 85(1), 45-58 (2012-03-31) Guanfacine extended release as adjunctive therapy to psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.Ann C Childress Advances in therapy, 29(5), 385-400 (2012-05-23) A case of excessive weight gain with guanfacine extended release: 9.53 kg in 4 weeks.Mehnaz A Khan et al.Journal of child and adolescent psychopharmacology, 22(3), 256-257 (2012-04-28) [α2-Adrenergic agonists, and drugs for ADHD].Hans-Willi Clement et al.Pharmazie in unserer Zeit, 40(6), 503-509 (2011-10-27) Treatment patterns, adherence, and persistence in ADHD: a Canadian perspective.Jean Lachaine et al.Postgraduate medicine, 124(3), 139-148 (2012-06-14) Once-daily treatment of ADHD with guanfacine: patient implicationsStrange BC Neuropsychiatric Disease and Treatment, 4(3), 499-499 (2008) Unintentional pediatric exposures to central alpha-2 agonists reported to the National Poison Data System.George Sam Wang et al.The Journal of pediatrics, 164(1), 149-152 (2013-10-08) Dried blood spots as a sampling technique for the quantitative determination of guanfacine in clinical studies.Yuanyuan Li et al.Bioanalysis, 3(22), 2501-2514 (2011-11-30) Adjuvants to prolong the local anesthetic effects of coated microneedle products.Ying Zhang et al.International journal of pharmaceutics, 439(1-2), 187-192 (2012-10-02) Psychometric validation of the Weiss Functional Impairment Rating Scale-Parent Report Form in children and adolescents with attention-deficit/hyperactivity disorder.Kavita Gajria et al.Health and quality of life outcomes, 13, 184-184 (2015-11-19)

备注